Shots:
Iris shared the specifics of the launch of the UCB’s Innovators campaign. The campaign spotlights the R&D employees’ perspectives on innovation and aims to highlight why innovation is a key driving force at UCB for bettering the lives of patients
She gave her thoughts on how UCB is adopting innovative AI programs that use…
Shots:
Jason shared his views on the launch of Metabolon, Inc.’s new Oxysterols Targeted Panel, highlighting its key features
He told how the panel measures 12 oxysterols and related sterols of biological significance to identify biomarkers for the prediction and early detection of cardiovascular diseases, neurodegenerative diseases, and cancer
The interview gives a profound understanding…
Introduction
What is more beautiful than a beautiful smile? It boosts one’s self-confidence. But if you stopped smiling, there might be something wrong with your gum and teeth. This condition can dampen your spirits and confidence. Take the problems seriously.
In that case, you might need cosmetic dentistry. It is the right choice for you.…
Shots:
Zack Usilton spoke about their partnerships with Reston ENT. He also elaborated on their past collaborations with some of the allergy groups
He also spoke on how these alliances will help Senta Partners to expand its footprint across 57 locations in 5 states in the Mid-Atlantic region
The interview gives an understanding of Senta…
The signs and symptoms of a potential vaccine injury can vary. They may include symptoms such as severe pain or swelling at the injection site, whole-body rashes or hives, fever, difficulty breathing or swallowing, extreme fatigue, vomiting, or swollen lymph nodes.
Other adverse reactions that could be attributed to a vaccine injury include neurological disorders…
Shots:
Laura gave an overview of Human acellular vessels (HAV). She talked about the six-month results of the HAV in a non-human primate model of CABG presented at the annual American Heart Association (AHA) Scientific Sessions 2022
She also elaborated on the construction and development of the CABG model and how it treats blocked arteries…
Shots:
Steffen shared the details of the first patient enrolled in the P-II study of Aphaia Pharma’s lead product APH-012 to induce weight loss in individuals with obesity
He briefed the PharmaShots team about the study design of the P-II trial and also elaborated on the results from the P-I study
The interview shows how…
Active Ingredient: dulaglutide
Dosage Forms & Strengths:
Injection: 0.75 mg/0.5 mL, 1.5 mg/0.5 mL, 3 mg/0.5 mL, 4.5 mg/0.5 mL solution in a single-dose pen
Mechanism of Action: GLP-1 receptor agonist
First Approval: US (Sep 18, 2014), EU (Nov 25, 2014)
Revenue Analysis1
Trulicity is used for the treatment of type 2 diabetes and to reduce the risk…
Chitkara University and DeepSynergy presents the Pharma Tech Conclave 2023. The conference will be held on 3rd Mar 2023 from 9:00 am to 5:00 pm IST at the Chitkara College of Pharmacy, Chitkara University, Chandigarh. The global pharmaceutical industry is undergoing transformational changes due to advancements in technological innovations that aim to fundamentally alter how patients…
Shots:
Suresh Kannan discussed the latest semi-annual update to bring innovative revenue optimization and compliance solution for life sciences and high-tech innovators
He elaborated on the Fall 2022 product release, providing customers with tools to improve automation, efficiency, and profitability during economic uncertainty along with streamlined pricing communication
The interview gives an understanding of how…

